ATM mutations in B-cell chronic lymphocytic leukemia

Haematologica

Volumn 89, Issue 1, 2004, Pages 109-110

  Lähdesmäki, Aleksi ^a,b   Kimby, Eva ^a   Duke, Veronique ^c   Forani, Letizia ^c   Hammarström, Lennart ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Center for Biotechnology   (Sweden)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ataxia telangiectasia; ATM mutations; B cell chronic lymphocytic leukemia

Indexed keywords

ATM PROTEIN; DNA;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; B CELL LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME DELETION; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0842306996     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997;89:2516-22.
2. Starostik P, Manshouri T, O'Brien S, Freireich E, Kantarjian H, Haidar M, et al. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 1998;58:4552-7.
3. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999;59:24-7.
4. Schaffner C, Stilgenbauer S, Rappold GA, Döhner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999;94:748-53.
5. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999;353:26-9.
6. Stankovic T, Stewart GS, Fegan C, Biggs P, Last J, Byrd PJ, et al. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 2002;99:300-9.
7. Yuille MR, Condie A, Hudson CD, Bradshaw PS, Stone EM, Matutes E, et al. ATM mutations are rare in familial chronic lymphocytic leukemia. Blood 2002;100:603-9.
8. Ishibe N, Sgambati MT, Dean M, Goldin LR, Albitar M, Manshouri T, et al. ATM mutations and protein expression are not associated with familial B-CLL cases. Leuk Res 2003;27:973-5.
9. Vorechovsky I, Luo L, Ortmann E, Steinmann D, Dork T. Missense mutations in ATM and cancer risk. Lancet 1999;353:1276.
10. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 1998;62:334-45.
11. Teraoka SN, Malone KE, Doody DR, Suter NM, Ostrander EA, Daling JR, et al. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer 2001;92:479-87.
12. Lähdesmäki A, Arinbjarnarson K, Arvidsson J, El Segaier M, Fasth A, Fernell E, et al. Ataxia-telangiectasia surveyed in Sweden. Läkartidningen 2000;97:4461-7.
13. Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM. ATM mutations in sporadic lymphoid tumours. Leuk Lymphoma 2002;43:1563-71.
14. Duke VM, Gandini D, Sherrington PD, Lin K, Heelan B, Amlot P, et al. VH gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003;88:1259-71.